Cardiff Oncology (CRDF) remains a single-asset biotech, with its thesis reliant on onvansertib targeting PLK1 in difficult-to ...

J&J shares positive long-term results of Rybrevant study for RAS/BRAF wild-type metastatic colorectal cancer at ASCO ...

The global laparoscopic instrument market reached USD 10.8 billion in 2020 and is forecasted to reach USD 22.6 billion by 2027, with a CAGR of 11.7% during 2021-2027. Factors such as the shift towards ...

Market OverviewThe global ostomy devices market is projected to grow at a healthy rate of 4–5% and is expected to reach approximately USD 3.2 billion by 2026. This steady expansion is driven by rising ...

Nutrition intake fundamentally shapes the composition and function of the gut microbiota, and dysregulation of this microbial ecosystem is a primary driver ...

Night work keeps hospitals open, factories humming and deliveries moving while most people sleep, but a growing body of research suggests that this schedule may quietly chip away at long‑term health.

Treatment with a GLP-1 receptor agonist (RA) may offer a survival advantage in patients with colon cancer and obesity. In a real-world analysis of nearly 7000 patients with colon cancer, those taking ...

New research links ultra-processed food with a higher colon cancer risk. The risk jumped 1.5 times in people with diets heavy in ultra-processed foods. Here’s what you need to know to help prevent ...

Sarah Basore, an Overland Park resident who is living with Stage 4 colon cancer, began clinical trials in August, which require weekly drives to Nashville. The current regime has stabilized her ...

Panelists discuss how available third-line therapies, such as FTD/TPI, regorafenib, and others, are chosen based on survival data, safety, and patient quality of life. Panelists discuss the ...